chr15-74411642-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_003612.5(SEMA7A):c.1491C>T(p.Gly497=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0012 in 1,612,364 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0064 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 11 hom. )
Consequence
SEMA7A
NM_003612.5 synonymous
NM_003612.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.48
Genes affected
SEMA7A (HGNC:10741): (semaphorin 7A (JohnMiltonHagen blood group)) This gene encodes a member of the semaphorin family of proteins. The encoded preproprotein is proteolytically processed to generate the mature glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein. The encoded protein is found on activated lymphocytes and erythrocytes and may be involved in immunomodulatory and neuronal processes. The encoded protein carries the John Milton Hagen (JMH) blood group antigens. Mutations in this gene may be associated with reduced bone mineral density (BMD). Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 15-74411642-G-A is Benign according to our data. Variant chr15-74411642-G-A is described in ClinVar as [Benign]. Clinvar id is 3042116.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-3.48 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00641 (976/152250) while in subpopulation AFR AF= 0.0221 (920/41544). AF 95% confidence interval is 0.021. There are 10 homozygotes in gnomad4. There are 481 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 BG,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEMA7A | NM_003612.5 | c.1491C>T | p.Gly497= | synonymous_variant | 12/14 | ENST00000261918.9 | |
SEMA7A | NM_001146029.3 | c.1449C>T | p.Gly483= | synonymous_variant | 11/13 | ||
SEMA7A | NM_001146030.3 | c.996C>T | p.Gly332= | synonymous_variant | 12/14 | ||
SEMA7A | XM_047433177.1 | c.1368C>T | p.Gly456= | synonymous_variant | 12/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEMA7A | ENST00000261918.9 | c.1491C>T | p.Gly497= | synonymous_variant | 12/14 | 1 | NM_003612.5 | P1 | |
SEMA7A | ENST00000543145.6 | c.1449C>T | p.Gly483= | synonymous_variant | 11/13 | 2 | |||
SEMA7A | ENST00000542748.6 | c.996C>T | p.Gly332= | synonymous_variant | 12/14 | 5 | |||
SEMA7A | ENST00000569617.1 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00639 AC: 972AN: 152132Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
972
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00155 AC: 385AN: 248786Hom.: 0 AF XY: 0.00113 AC XY: 152AN XY: 134614
GnomAD3 exomes
AF:
AC:
385
AN:
248786
Hom.:
AF XY:
AC XY:
152
AN XY:
134614
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000658 AC: 961AN: 1460114Hom.: 11 Cov.: 33 AF XY: 0.000566 AC XY: 411AN XY: 726314
GnomAD4 exome
AF:
AC:
961
AN:
1460114
Hom.:
Cov.:
33
AF XY:
AC XY:
411
AN XY:
726314
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00641 AC: 976AN: 152250Hom.: 10 Cov.: 32 AF XY: 0.00646 AC XY: 481AN XY: 74428
GnomAD4 genome
AF:
AC:
976
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
481
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SEMA7A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at